Výsledky vyhledávání - Masafumi Ikeda

Upřesnit hledání
  1. 1
    Radiofrequency Ablation and Percutaneous Ethanol Injection in Patients with Small Hepatocellular Carcinoma: a Comparative Study

    Radiofrequency Ablation and Percutaneous Ethanol Injection in Patients with Small Hepatocellular Carcinoma: a Comparative Study Autor Masafumi Ikeda

    Vydáno 2001
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Immunotherapy for hepatocellular carcinoma: current status and future perspectives

    Immunotherapy for hepatocellular carcinoma: current status and future perspectives Autor Takuji Okusaka, Masafumi Ikeda

    Vydáno 2018
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Phase II study of S-1 in patients with advanced biliary tract cancer

    Phase II study of S-1 in patients with advanced biliary tract cancer Autor Hideki Ueno, Takuji Okusaka, Masafumi Ikeda, Yoriko Takezako, Chigusa Morizane

    Vydáno 2004
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Chemotherapy for hepatocellular carcinoma: current status and future perspectives

    Chemotherapy for hepatocellular carcinoma: current status and future perspectives Autor Masafumi Ikeda, Chigusa Morizane, Makoto Ueno, Takuji Okusaka, Hiroshi Ishii, Junji Furuse

    Vydáno 2017
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  5. 5
    New developments in systemic therapy for advanced biliary tract cancer

    New developments in systemic therapy for advanced biliary tract cancer Autor Chigusa Morizane, Makoto Ueno, Masafumi Ikeda, Takuji Okusaka, Hiroshi Ishii, Junji Furuse

    Vydáno 2018
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  6. 6
    A phase 1b study of transforming growth factor-beta receptor I inhibitor galunisertib in combination with sorafenib in Japanese patients with unresectable hepatocellular carcinoma

    A phase 1b study of transforming growth factor-beta receptor I inhibitor galunisertib in combination with sorafenib in Japanese patients with unresectable hepatocellular carcinoma Autor Masafumi Ikeda, Manabu Morimoto, Masaomi Tajimi, Kōichi Inoue, Karim A. Benhadji, Michael Lahn, Daisuke Sakai

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Phase <scp>II</scp> study of <scp>FOLFIRINOX</scp> for chemotherapy‐naïve Japanese patients with metastatic pancreatic cancer

    Phase <scp>II</scp> study of <scp>FOLFIRINOX</scp> for chemotherapy‐naïve Japanese patients with metastatic pancreatic cancer Autor Takuji Okusaka, Masafumi Ikeda, Akira Fukutomi, Tatsuya Ioka, Junji Furuse, Shinichi Ohkawa, Hiroyuki Isayama, Narikazu Boku

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future

    Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future Autor Masafumi Ikeda, Shuichi Mitsunaga, Izumi Ohno, Yusuke Hashimoto, Hideaki Takahashi, Kazuo Watanabe, Kumiko Umemoto, Takuji Okusaka

    Vydáno 2015
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety-Assessment Cohort

    Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety-Assessment Cohort Autor Toshihiko Doi, Yutaka Fujiwara, Takafumi Koyama, Masafumi Ikeda, Christoph Helwig, Morihiro Watanabe, Yulia Vugmeyster, Masatoshi Kudo

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer

    Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer Autor Takuji Okusaka, Yukako Ιtο, Hideki Ueno, Masafumi Ikeda, Yoriko Takezako, Chigusa Morizane, Yoshikazu Kagami, Hiroshi Ikeda

    Vydáno 2004
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Japanese phase I study of<scp>GC</scp>33, a humanized antibody against glypican‐3 for advanced hepatocellular carcinoma

    Japanese phase I study of<scp>GC</scp>33, a humanized antibody against glypican‐3 for advanced hepatocellular carcinoma Autor Masafumi Ikeda, Shinichi Ohkawa, Takuji Okusaka, Shuichi Mitsunaga, Satoshi Kobayashi, Chigusa Morizane, Ikue Suzuki, S. Yamamoto, Junji Furuse

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)

    A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT) Autor Kohei Nakachi, Masaru Konishi, Masafumi Ikeda, Junki Mizusawa, Junko Eba, Takuji Okusaka, Hiroshi Ishii, Haruhiko Fukuda, Junji Furuse

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506

    Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506 Autor Hiroshi Ishii, J. Furuse, Narikazu Boku, Takuji Okusaka, Masafumi Ikeda, S. Ohkawa, Akira Fukutomi, Yasuo Hamamoto, K. Nakamura, Hiroyuki Fukuda

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

    Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma Autor Masafumi Ikeda, Takuji Okusaka, Shuichi Mitsunaga, Hideki Ueno, Toshiyuki Tamai, Takuya Suzuki, Seiichi Hayato, Tadashi Kadowaki, Kiwamu Okita, Hiromitsu Kumada

    Vydáno 2015
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Randomized phase <scp>II</scp> study of gemcitabine plus <scp>S</scp>‐1 versus <scp>S</scp>‐1 in advanced biliary tract cancer: A <scp>J</scp>apan <scp>C</scp>linical <scp>O</scp>ncology <scp>G</scp>roup trial (JCOG 0805)

    Randomized phase <scp>II</scp> study of gemcitabine plus <scp>S</scp>‐1 versus <scp>S</scp>‐1 in advanced biliary tract cancer: A <scp>J</scp>apan <scp>C</scp>linical <scp>O</scp>n... Autor Chigusa Morizane, Takuji Okusaka, Junki Mizusawa, Atsuo Takashima, Makoto Ueno, Masafumi Ikeda, Yasuo Hamamoto, Hiroshi Ishii, Narikazu Boku, Junji Furuse

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer

    Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer Autor Shuichi Mitsunaga, Masafumi Ikeda, Satoshi Shimizu, Izumi Ohno, J. Furuse, Masatoshi Inagaki, Sayumi Higashi, Hiroyuki Kato, Keiji Terao, Atsushi Ochiai

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

    Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics Autor Yu Sunakawa, Junji Furuse, Takuji Okusaka, Masafumi Ikeda, Fumio Nagashima, Hideki Ueno, Shuichi Mitsunaga, Kensei Hashizume, Yuichiro Ito, Yasutsuna Sasaki

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer

    A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer Autor Eiichiro Suzuki, Masafumi Ikeda, Takuji Okusaka, Shoji Nakamori, Shinichi Ohkawa, Tatsuya Nagakawa, Narikazu Boku, Hiroaki Yanagimoto, Tosiya Sato, Junji Furuse

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results

    Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results Autor Makoto Ueno, Masafumi Ikeda, Takashi Sasaki, Fumio Nagashima, Nobumasa Mizuno, Satoshi Shimizu, Hiroki Ikezawa, Nozomi Hayata, Ryo Nakajima, Chigusa Morizane

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON

    Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON Autor Masatoshi Kudo, Masafumi Ikeda, Tadatoshi Takayama, Kazushi Numata, Namiki Izumi, Junji Furuse, Takuji Okusaka, Masumi Kadoya, Satoshi Yamashita, Yuichiro Ito, Norihiro Kokudo

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: